PROGRAM DESCRIPTION

In this recording of a live symposium for geriatric psychiatrists that took place on March 8, 2016 in Washington, DC, three leading experts explore the challenges that complicate the treatment of geriatric patients with MDD. The content of the program centers on cognitive symptoms of depression, use of measurement-based care in MDD treatment, and clinical trial data on newer agents/strategies shown to positively impact cognition. Guidance for the implementation of shared decision-making is provided via an on-stage, panel interview of an actual geriatric patient with MDD, who shares his experiences with diagnosis and treatment.

INTENDED AUDIENCE

Psychiatrists and psychiatric allied health professionals

EDUCATIONAL OBJECTIVES

At the conclusion of this program, participants should be better able to:

  • Describe the link between untreated symptoms of depression—particularly cognitive deficits—and dementia in geriatric patients with major depressive disorder (MDD)

  • Implement individualized treatment strategies for geriatric patients with MDD

  • Increase the proportion of patients with MDD aged 65 years and older whose symptoms are reassessed using a validated, quantitative assessment tool within 3 months of initiating antidepressant therapy

  • Utilize motivational interviewing and other strategies to actively engage geriatric patients with MDD in their treatment plans

This program is jointly provided by The American Association for Geriatric Psychiatry

This course expires on May 17, 2017. 

To take the course, click here or visit mycme.com